Over the last 7 days, the Life Sciences industry has dropped 3.4%, driven by pullbacks in Thermo Fisher Scientific and Agilent Technologies of 2.8% and 13%, respectively. Over the past 12 months, the industry was up 3.4%. Earnings are forecast to grow by 17% annually.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 04 Jun 2024 | US$702.1b | US$141.3b | US$12.4b | 38.2x | 56.5x | 5x |
Thu, 02 May 2024 | US$706.3b | US$141.5b | US$12.7b | 39.4x | 55.8x | 5x |
Sat, 30 Mar 2024 | US$744.3b | US$142.1b | US$12.8b | 44x | 58.1x | 5.2x |
Mon, 26 Feb 2024 | US$729.9b | US$142.1b | US$12.4b | 43.7x | 58.9x | 5.1x |
Wed, 24 Jan 2024 | US$697.0b | US$153.8b | US$14.2b | 35.8x | 49.2x | 4.5x |
Fri, 22 Dec 2023 | US$687.0b | US$153.8b | US$14.2b | 37.5x | 48.2x | 4.5x |
Sun, 19 Nov 2023 | US$614.3b | US$153.9b | US$13.9b | 33.5x | 44.2x | 4x |
Tue, 17 Oct 2023 | US$632.5b | US$154.6b | US$11.2b | 33.2x | 56.5x | 4.1x |
Thu, 14 Sep 2023 | US$692.7b | US$154.6b | US$11.2b | 33.1x | 61.8x | 4.5x |
Sat, 12 Aug 2023 | US$725.3b | US$154.7b | US$11.5b | 32x | 63.1x | 4.7x |
Mon, 10 Jul 2023 | US$685.3b | US$152.4b | US$12.5b | 29.6x | 54.8x | 4.5x |
Wed, 07 Jun 2023 | US$682.6b | US$152.4b | US$12.5b | 29.1x | 54.6x | 4.5x |
Fri, 05 May 2023 | US$699.3b | US$152.7b | US$9.6b | 28.3x | 72.5x | 4.6x |
Sun, 02 Apr 2023 | US$728.9b | US$154.6b | US$10.8b | 27x | 67.5x | 4.7x |
Tue, 28 Feb 2023 | US$711.1b | US$154.3b | US$11.2b | 29.8x | 63.5x | 4.6x |
Thu, 26 Jan 2023 | US$755.4b | US$155.5b | US$9.0b | 30.9x | 84x | 4.9x |
Sat, 24 Dec 2022 | US$743.5b | US$155.2b | US$8.8b | 28.8x | 84.7x | 4.8x |
Mon, 21 Nov 2022 | US$749.5b | US$154.9b | US$8.8b | 27.8x | 84.7x | 4.8x |
Wed, 19 Oct 2022 | US$727.4b | US$152.5b | US$17.0b | 26x | 42.8x | 4.8x |
Fri, 16 Sep 2022 | US$767.7b | US$152.3b | US$17.3b | 29.3x | 44.4x | 5x |
Sun, 14 Aug 2022 | US$845.8b | US$152.1b | US$17.3b | 32.6x | 49x | 5.6x |
Tue, 12 Jul 2022 | US$745.5b | US$148.1b | US$20.1b | 30.6x | 37.1x | 5x |
Thu, 09 Jun 2022 | US$764.0b | US$148.1b | US$20.1b | 31.9x | 38x | 5.2x |
Sat, 07 May 2022 | US$749.3b | US$147.7b | US$20.0b | 31.2x | 37.4x | 5.1x |
Mon, 04 Apr 2022 | US$884.8b | US$146.5b | US$25.3b | 36.7x | 34.9x | 6x |
Wed, 02 Mar 2022 | US$839.5b | US$146.1b | US$25.3b | 37.4x | 33.2x | 5.7x |
Fri, 28 Jan 2022 | US$801.4b | US$138.0b | US$27.3b | 37.3x | 29.3x | 5.8x |
Sun, 26 Dec 2021 | US$981.9b | US$138.0b | US$27.3b | 44.6x | 35.9x | 7.1x |
Tue, 23 Nov 2021 | US$965.2b | US$137.8b | US$27.1b | 45.4x | 35.6x | 7x |
Thu, 21 Oct 2021 | US$737.7b | US$106.0b | US$18.5b | 47.4x | 39.8x | 7x |
Sat, 18 Sep 2021 | US$757.4b | US$105.9b | US$18.6b | 51.6x | 40.7x | 7.2x |
Mon, 16 Aug 2021 | US$722.6b | US$105.8b | US$18.7b | 49.7x | 38.7x | 6.8x |
37.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.62% | |
Healthcare | -0.65% | |
Life Sciences | -3.43% | |
Clinical Research and Equipment | -3.43% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ICLR ICON | US$323.49 | 0.9% +US$229.0m | 47.7% | PE39.2x | |
AVTR Avantor | US$24.26 | 0.5% +US$81.5m | 19.9% | PE63.4x | |
SHC Sotera Health | US$11.46 | 2.3% +US$73.6m | -21.9% | PE59.5x | |
QGEN Qiagen | US$44.00 | 0.6% +US$59.9m | -7.0% | PE29x | |
BIO Bio-Rad Laboratories | US$288.96 | 0.6% +US$49.9m | -21.6% | PS3.2x |